<p>Disease-free survival by treatment (chemoradiation therapy or radiation therapy alone).</p
<p>Disease-free survival (A) and overall survival (B) of patients presenting with esophageal cancer ...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan–Meier analysis of disease-free survival time in the enrolled patients.</p
<p>Overall survival by treatment (chemoradiation therapy or radiation therapy alone).</p
<p>Disease-free survival after radiotherapy for recurrent and metastatic cervical cancer.</p
<p>Distant metastasis-free survival of patients with or without radiotherapy.</p
<p>Locoregional relapse-free survival of patients with or without radiotherapy.</p
<p>Disease-free survival (A) in all patients (N = 184) and (B) according to stages.</p
<p>Progression-free survival in relation to clinical-pathological characteristics of patients.</p
<p>Progression Free Survival According to the Presence of a Measurable Enhancing Lesion.</p
<p>Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group ...
<p>Progression-free survival after radiotherapy for recurrent and metastatic cervical cancer.</p
<p>Progression-free survival A) in all, B) in patients stratified by non-responders and responders, ...
<p>Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.</p
<p>Disease-free survival of the patients by three risk groups according to the predicted risk probab...
<p>Disease-free survival (A) and overall survival (B) of patients presenting with esophageal cancer ...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan–Meier analysis of disease-free survival time in the enrolled patients.</p
<p>Overall survival by treatment (chemoradiation therapy or radiation therapy alone).</p
<p>Disease-free survival after radiotherapy for recurrent and metastatic cervical cancer.</p
<p>Distant metastasis-free survival of patients with or without radiotherapy.</p
<p>Locoregional relapse-free survival of patients with or without radiotherapy.</p
<p>Disease-free survival (A) in all patients (N = 184) and (B) according to stages.</p
<p>Progression-free survival in relation to clinical-pathological characteristics of patients.</p
<p>Progression Free Survival According to the Presence of a Measurable Enhancing Lesion.</p
<p>Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group ...
<p>Progression-free survival after radiotherapy for recurrent and metastatic cervical cancer.</p
<p>Progression-free survival A) in all, B) in patients stratified by non-responders and responders, ...
<p>Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.</p
<p>Disease-free survival of the patients by three risk groups according to the predicted risk probab...
<p>Disease-free survival (A) and overall survival (B) of patients presenting with esophageal cancer ...
<p>Kaplan-Meier estimates of (a) overall survival, (b) distant progression-free survival and (c) loc...
<p>Kaplan–Meier analysis of disease-free survival time in the enrolled patients.</p
DOI
Add to ORKG